Atea Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: AVIR
Share price (4/8/26): $5.93
Market cap (4/8/26): $472 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Post-effective amendment to an automatic shelf registration

Ownership Filter

Vanguard Group Inc

Corcoran Andrea

BML Investment Partners, L.P.

Horga Maria Arantxa

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

To Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference

Reports Third Quarter 2025 Financial Results and Provides Business Update

Reports Second Quarter 2025 Financial Results and Provides Business Update

Shareholder Vote Results

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Proxy materials by non-management

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness